Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Chronic Spontaneous Urticaria Market Report 2024

Chronic Spontaneous Urticaria Global Market Report 2025 – By Treatment (Medication, Phototherapy, Other Treatments), By Route Of Administration (Oral, Topical, Parenteral, Other Routes Of Administration), By Diagnosis (Physical Examination, Blood Test, Allergy Test, Other Diagnosis), By End-Users (Hospitals, Specialty Clinics, Homecare, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

Chronic Spontaneous Urticaria Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Chronic Spontaneous Urticaria Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Chronic Spontaneous Urticaria Market Definition

Chronic spontaneous urticaria (CSU) is a skin condition characterized by the recurrent appearance of hives (raised, red, itchy welts) and angioedema (swelling) lasting for more than six weeks, without an identifiable external trigger. The exact cause of CSU is often unknown, but IT may involve an autoimmune component where the body's immune system mistakenly attacks healthy skin cells. Treatment focuses on symptom management, primarily using antihistamines and, in more severe cases, other medications such as biologics.

The main treatments for chronic spontaneous urticaria are medication, phototherapy, and others. Chronic spontaneous urticaria medication typically includes antihistamines as first-line treatment, with options ranging from non-sedating to sedating types based on symptom severity and patient response. Treatment administration routes include oral, Topical, parenteral, and others. Diagnosis involves physical examination, blood tests, and allergy testing and is used by various end users of treatments, including hospitals, specialty clinics, home care settings, and others.

Chronic Spontaneous Urticaria Market Segmentation

The chronic spontaneous urticaria market covered in this report is segmented –

1) By Treatment: Medication, Phototherapy, Other Treatments

2) By Route Of Administration: Oral, Topical, Parenteral, Other Routes Of Administration

3) By Diagnosis: Physical Examination, Blood Test, Allergy Test, Other Diagnosis

4) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Medication: Antihistamines, Leukotriene Receptor Antagonists, Monoclonal Antibodies, immunosuppressants, Corticosteroids (Oral and Topical)

2) By Phototherapy: UVB Phototherapy, UVA Phototherapy, Narrowband UVB Therapy

3) By Other Treatments: Alternative Therapies, Dietary Modifications, Psychotherapy (for Stress-Related Triggers)

Chronic Spontaneous Urticaria Market Size and growth rate 2025 to 2029: Graph

Chronic Spontaneous Urticaria Market Size 2025 And Growth Rate

The chronic spontaneous urticaria market size has grown strongly in recent years. It will grow from $2.06 billion in 2024 to $2.23 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to improved diagnostic tools, growing awareness among healthcare, patient advocacy and support groups, ongoing studies and clinical trials exploring new therapies, and growing healthcare expenditure.

Chronic Spontaneous Urticaria Market Growth Forecast

The chronic spontaneous urticaria market size is expected to see strong growth in the next few years. It will grow to $3.08 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to an increase in the number of diagnosed CSU cases, a growing patient pool, healthcare infrastructure development, favorable regulatory environment facilitating, patient-centric care models, and economic growth in emerging markets. Major trends in the forecast period include technology innovations, biological therapy advancements, personalized medicine, telemedicine and digital health, advanced diagnostic tools, AI and machine learning, and surging drug approvals and launches.

Book your 30 minutes free consultation with our research experts

Contact Us

Chronic Spontaneous Urticaria Market Driver: Impact Of Increasing Alcohol Consumption On The Chronic Spontaneous Urticaria Market

Increasing alcohol consumption is expected to propel the growth of the chronic spontaneous urticaria market going forward. The rising consumption of alcohol can be attributed to various factors, such as social norms, stress, advertising, affordability, and availability. Alcohol consumption can potentially exacerbate symptoms of chronic spontaneous urticaria in some individuals, leading to increased hives and swelling. For instance, in February 2024, according to rehabs.UK, a UK-based provider of addiction recovery support and advice services, 55% of men reported weekly alcohol consumption, while 41% of women. Additionally, 8% of men reported drinking alcohol almost daily, compared to 5% of women. Over the years from 2021 to 2022, there were 342,795 hospital admissions solely attributable to alcohol, translating to a rate of 626 admissions per 100,000 people. Therefore, increasing alcohol consumption is driving the growth of the chronic spontaneous urticaria market.

Global Chronic Spontaneous Urticaria Market Major Players

Major companies operating in the chronic spontaneous urticaria market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Cipla Limited, Genentech Inc., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Celltrion Inc., Allakos Inc., United BioPharma Inc.

Global Chronic Spontaneous Urticaria Market Trend: Development Of Next-Generation Briquilimab (JSP191) To Enhance Treatment Efficacy

Major companies operating in the chronic spontaneous urticaria market are developing advanced next-generation Briquilimab (JSP191) to enhance treatment efficacy and reduce dosing frequency. Next-generation Briquilimab (JSP191) refers to a monoclonal antibody designed to target and deplete specific immune cells, particularly targeting CD47, such as chronic spontaneous urticaria. For instance, in November 2023, Jasper Therapeutics Inc., a US-based clinical-stage biotechnology company, announced that IT has dosed its first patient in a Phase 1b/2a clinical study of Briquilimab for chronic spontaneous urticaria (CSU). This achievement is a critical step in assessing the safety and effectiveness of Briquilimab, a next-generation monoclonal antibody that targets CD47, in the treatment of this recurrent hive and itching problem. The study aims to assess how well Briquilimab can alleviate symptoms and improve quality of life for patients suffering from CSU.

Chronic Spontaneous Urticaria Market Merger And Acquisition: Novan Inc. Enhances Commercial Capabilities Through Acquisition Of EPI Health LLC

In March 2022, Novan Inc., a US-based specialty dermatology company, acquired EPI Health LLC for an undisclosed amount. The acquisition creates a robust commercial infrastructure for Novan as IT prepares for the potential FDA approval of its lead product candidate, SB206 (berdazimer gel 10.3%), for the treatment of molluscum contagiosum. EPI Health LLC is a US-based pharmaceutical company that provides Xyzal (levocetirizine) for the treatment of uncomplicated skin manifestations.

Regional Outlook For The Global Chronic Spontaneous Urticaria Market

North America was the largest region in the chronic spontaneous urticaria market in 2024. The regions covered in the chronic spontaneous urticaria market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the chronic spontaneous urticaria market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Chronic Spontaneous Urticaria Market?

The chronic spontaneous urticaria market consists of revenues earned by entities by providing services such as diagnostic services and medical consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. The chronic spontaneous urticaria market also includes sales of antihistamines, corticosteroids, and cyclosporine. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Chronic Spontaneous Urticaria Industry?

The chronic spontaneous urticaria research report is one of a series of new reports from The Business Research Company that provides chronic spontaneous urticaria market statistics, including the chronic spontaneous urticaria industry's global market size, regional shares, competitors with a chronic spontaneous urticaria market share, detailed chronic spontaneous urticaria market segments, market trends and opportunities, and any further data you may need to thrive in the chronic spontaneous urticaria industry. This chronic spontaneous urticaria market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Chronic Spontaneous Urticaria Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $2.23 billion
Revenue Forecast In 2034 $3.08 billion
Growth Rate CAGR of 8.4% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Treatment: Medication, Phototherapy, Other Treatments
2) By Route Of Administration: Oral, Topical, Parenteral, Other Routes Of Administration
3) By Diagnosis: Physical Examination, Blood Test, Allergy Test, Other Diagnosis
4) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users Subsegments: 1) By Medication: Antihistamines, Leukotriene Receptor Antagonists, Monoclonal Antibodies, Immunosuppressants, Corticosteroids (Oral and Topical)
2) By Phototherapy: UVB Phototherapy, UVA Phototherapy, Narrowband UVB Therapy
3) By Other Treatments: Alternative Therapies, Dietary Modifications, Psychotherapy (for Stress-Related Triggers)
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Cipla Limited, Genentech Inc., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Celltrion Inc., Allakos Inc., United BioPharma Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Chronic Spontaneous Urticaria Market Characteristics

    3. Chronic Spontaneous Urticaria Market Trends And Strategies

    4. Chronic Spontaneous Urticaria Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    5. Global Chronic Spontaneous Urticaria Growth Analysis And Strategic Analysis Framework

    5.1. Global Chronic Spontaneous Urticaria PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Chronic Spontaneous Urticaria Market Growth Rate Analysis

    5.4. Global Chronic Spontaneous Urticaria Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Chronic Spontaneous Urticaria Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Chronic Spontaneous Urticaria Total Addressable Market (TAM)

    6. Chronic Spontaneous Urticaria Market Segmentation

    6.1. Global Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Medication

    Phototherapy

    Other Treatments

    6.2. Global Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Oral

    Topical

    Parenteral

    Other Administrations

    6.3. Global Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Physical Examination

    Blood Test

    Allergy Test

    Other Diagnosis

    6.4. Global Chronic Spontaneous Urticaria Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals

    Specialty Clinics

    Homecare

    Other End-Users

    6.5. Global Chronic Spontaneous Urticaria Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Antihistamines

    Leukotriene Receptor Antagonists

    Monoclonal Antibodies

    Immunosuppressants

    Corticosteroids (Oral and Topical)

    6.6. Global Chronic Spontaneous Urticaria Market, Sub-Segmentation Of Phototherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    UVB Phototherapy

    UVA Phototherapy

    Narrowband UVB Therapy

    6.7. Global Chronic Spontaneous Urticaria Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Alternative Therapies

    Dietary Modifications

    Psychotherapy (for Stress-Related Triggers)

    7. Chronic Spontaneous Urticaria Market Regional And Country Analysis

    7.1. Global Chronic Spontaneous Urticaria Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Chronic Spontaneous Urticaria Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Chronic Spontaneous Urticaria Market

    8.1. Asia-Pacific Chronic Spontaneous Urticaria Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Chronic Spontaneous Urticaria Market

    9.1. China Chronic Spontaneous Urticaria Market Overview

    9.2. China Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Chronic Spontaneous Urticaria Market

    10.1. India Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Chronic Spontaneous Urticaria Market

    11.1. Japan Chronic Spontaneous Urticaria Market Overview

    11.2. Japan Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Chronic Spontaneous Urticaria Market

    12.1. Australia Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Chronic Spontaneous Urticaria Market

    13.1. Indonesia Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Chronic Spontaneous Urticaria Market

    14.1. South Korea Chronic Spontaneous Urticaria Market Overview

    14.2. South Korea Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Chronic Spontaneous Urticaria Market

    15.1. Western Europe Chronic Spontaneous Urticaria Market Overview

    15.2. Western Europe Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Chronic Spontaneous Urticaria Market

    16.1. UK Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Chronic Spontaneous Urticaria Market

    17.1. Germany Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Chronic Spontaneous Urticaria Market

    18.1. France Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Chronic Spontaneous Urticaria Market

    19.1. Italy Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Chronic Spontaneous Urticaria Market

    20.1. Spain Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Chronic Spontaneous Urticaria Market

    21.1. Eastern Europe Chronic Spontaneous Urticaria Market Overview

    21.2. Eastern Europe Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Chronic Spontaneous Urticaria Market

    22.1. Russia Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Chronic Spontaneous Urticaria Market

    23.1. North America Chronic Spontaneous Urticaria Market Overview

    23.2. North America Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Chronic Spontaneous Urticaria Market

    24.1. USA Chronic Spontaneous Urticaria Market Overview

    24.2. USA Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Chronic Spontaneous Urticaria Market

    25.1. Canada Chronic Spontaneous Urticaria Market Overview

    25.2. Canada Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Chronic Spontaneous Urticaria Market

    26.1. South America Chronic Spontaneous Urticaria Market Overview

    26.2. South America Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Chronic Spontaneous Urticaria Market

    27.1. Brazil Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Chronic Spontaneous Urticaria Market

    28.1. Middle East Chronic Spontaneous Urticaria Market Overview

    28.2. Middle East Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Chronic Spontaneous Urticaria Market

    29.1. Africa Chronic Spontaneous Urticaria Market Overview

    29.2. Africa Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Chronic Spontaneous Urticaria Market Competitive Landscape And Company Profiles

    30.1. Chronic Spontaneous Urticaria Market Competitive Landscape

    30.2. Chronic Spontaneous Urticaria Market Company Profiles

    30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

    31. Chronic Spontaneous Urticaria Market Other Major And Innovative Companies

    31.1. AstraZeneca plc

    31.2. Novartis AG

    31.3. GlaxoSmithKline plc

    31.4. Eli Lilly and Company

    31.5. Amgen Inc.

    31.6. Teva Pharmaceutical Industries Ltd.

    31.7. Sun Pharmaceutical Industries Ltd.

    31.8. Aurobindo Pharma Limited

    31.9. Cipla Limited

    31.10. Genentech Inc.

    31.11. Dr. Reddy's Laboratories Ltd.

    31.12. Hikma Pharmaceuticals plc

    31.13. Celltrion Inc.

    31.14. Allakos Inc.

    31.15. United BioPharma Inc.

    32. Global Chronic Spontaneous Urticaria Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Chronic Spontaneous Urticaria Market

    34. Recent Developments In The Chronic Spontaneous Urticaria Market

    35. Chronic Spontaneous Urticaria Market High Potential Countries, Segments and Strategies

    35.1 Chronic Spontaneous Urticaria Market In 2029 - Countries Offering Most New Opportunities

    35.2 Chronic Spontaneous Urticaria Market In 2029 - Segments Offering Most New Opportunities

    35.3 Chronic Spontaneous Urticaria Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Chronic Spontaneous Urticaria Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Chronic Spontaneous Urticaria Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Chronic Spontaneous Urticaria Market, Sub-Segmentation Of Phototherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Chronic Spontaneous Urticaria Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Chronic Spontaneous Urticaria Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Chronic Spontaneous Urticaria Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 79: Merck & Co. Inc. Financial Performance
  • Table 80: AbbVie Inc. Financial Performance
  • Table 81: Bayer AG Financial Performance
  • Table 82: Sanofi SA Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Chronic Spontaneous Urticaria Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Chronic Spontaneous Urticaria Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Chronic Spontaneous Urticaria Market, Sub-Segmentation Of Phototherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Chronic Spontaneous Urticaria Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Chronic Spontaneous Urticaria Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Chronic Spontaneous Urticaria Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 79: Merck & Co. Inc. Financial Performance
  • Figure 80: AbbVie Inc. Financial Performance
  • Figure 81: Bayer AG Financial Performance
  • Figure 82: Sanofi SA Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

Read More

How Will The Nuclear Medicine Market Grow In 2022?

Read More

What Is The Pediatric Imaging Market Overview In 2022?

Read More

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

Read More

Chronic Disease Management Global Market Report 2025 – By Service (Consulting Service, Implementation Service, Educational Service), By Delivery Mode (On-premise, Cloud-based, Web-based), By Disease Type (Cardiovascular Diseases, Diabetes, Cancer, Asthma, Chronic Obstructive Pulmonary Disorders), By End User (Providers, Payers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Chronic Lower Back Pain Global Market Report 2025 – By Type of Pain (Diskogenic Pain, Lumbar Spinal Stenosis, Sacroiliac Pain, Facet-Joint Pain, Radicular Pain, Muscular Pain, Other Types Of Pain), By Diagnosis (Clinical History, Physical Examination, Imaging Guidelines, Assessment of Pain), By End-User (Hospitals, Orthopedic Clinics, Ambulatory Surgery Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Chronic Obstructive Pulmonary Disease (COPD) Treatment Global Market Report 2025 – By Drug Class (Combination Therapy, Bronchodilators, Corticosteroids, Phosphodiesterase Type 4 Inhibitor, Mucokinetics, Other Drug Classes), By Type (Chronic Bronchitis, Emphysema), By End-User (Hospitals, Clinics, Homecare Settings) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Chronic Lymphocytic Leukemia Treatment Global Market Report 2025 – By Type (Aggressive CLL, Indolent CLL, Other Types), By Treatment (Targeted Drug Therapy, Chemotherapy, Bone Marrow Transplant, Immunotherapy), By Route of Administration (Oral, Parental, Other Route of Administration), By End-Users (Hospital, Diagnostic Laboratories, Research Institutes, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Chronic Kidney Disease Global Market Report 2025 – By Diagnosis (Blood Test, Urine Test, Imaging Test, Kidney Biopsy), By Treatment (Drugs, Dialysis, Kidney Transplant, ACE Inhibitors, Blood Test, Other Treatments), By Route of Administration (Oral, Intravenous, Subcutaneous), By End-User (Hospital And Clinics, Ambulatory Surgery Centers (ASCs), Dialysis Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Chronic Pain Global Market Report 2025 – By Product (Drug, Devices ), By Indication (Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications), By End User (Hospitals, Clinics, Research Organization) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Chronic Myeloid Leukemia (CML) Treatment Global Market Report 2025 – By Type (Targeted Therapy, Chemotherapy, Radiation Therapy, Splenectomy, Stem Cell Transplant), By Drug Type (Tyrosine Kinase Inhibitors, Antimetabolites, Other Drug Types), By Application (Hospitals, Clinic, Other Applications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Chronic Cough Global Market Report 2025 – By Drug Class (Antihistamines, Corticosteroids, Decongestants, Combination Drug, Antibiotics, Acid Blockers, Other Drug Classes), By Route Of Administration (Oral, Inhalational, Injectable, Other Route of Administrations), By End-Users (Hospitals, Homecare, Specialty Centers, Other End Users), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Chronic Spontaneous Urticaria market?

Chronic spontaneous urticaria (CSU) is a skin condition characterized by the recurrent appearance of hives (raised, red, itchy welts) and angioedema (swelling) lasting for more than six weeks, without an identifiable external trigger. The exact cause of CSU is often unknown, but it may involve an autoimmune component where the body's immune system mistakenly attacks healthy skin cells. Treatment focuses on symptom management, primarily using antihistamines and, in more severe cases, other medications such as biologics. For further insights on the Chronic Spontaneous Urticaria market, request a sample here

How will the Chronic Spontaneous Urticaria market drivers and restraints affect the market dynamics? What forces will shape the Chronic Spontaneous Urticaria industry going forward?

The Chronic Spontaneous Urticaria market major growth driver - Impact Of Increasing Alcohol Consumption On The Chronic Spontaneous Urticaria Market. For further insights on the Chronic Spontaneous Urticaria market, request a sample here

What is the forecast market size or the forecast market value of the Chronic Spontaneous Urticaria market?

The Chronic Spontaneous Urticaria market size has grown strongly in recent years. The chronic spontaneous urticaria market size has grown strongly in recent years. It will grow from $2.06 billion in 2024 to $2.23 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to improved diagnostic tools, growing awareness among healthcare, patient advocacy and support groups, ongoing studies and clinical trials exploring new therapies, and growing healthcare expenditure. The chronic spontaneous urticaria market size is expected to see strong growth in the next few years. It will grow to $3.08 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to an increase in the number of diagnosed CSU cases, a growing patient pool, healthcare infrastructure development, favorable regulatory environment facilitating, patient-centric care models, and economic growth in emerging markets. Major trends in the forecast period include technology innovations, biological therapy advancements, personalized medicine, telemedicine and digital health, advanced diagnostic tools, AI and machine learning, and surging drug approvals and launches. For further insights on the Chronic Spontaneous Urticaria market, request a sample here

How is the Chronic Spontaneous Urticaria market segmented?

The chronic spontaneous urticaria market covered in this report is segmented –
1) By Treatment: Medication, Phototherapy, Other Treatments
2) By Route Of Administration: Oral, Topical, Parenteral, Other Routes Of Administration
3) By Diagnosis: Physical Examination, Blood Test, Allergy Test, Other Diagnosis
4) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users
Subsegments:
1) By Medication: Antihistamines, Leukotriene Receptor Antagonists, Monoclonal Antibodies, Immunosuppressants, Corticosteroids (Oral and Topical)
2) By Phototherapy: UVB Phototherapy, UVA Phototherapy, Narrowband UVB Therapy
3) By Other Treatments: Alternative Therapies, Dietary Modifications, Psychotherapy (for Stress-Related Triggers) For further insights on the Chronic Spontaneous Urticaria market, request a sample here

Which region has the largest share of the Chronic Spontaneous Urticaria market? What are the other regions covered in the report?

North America was the largest region in the chronic spontaneous urticaria market in 2023. The regions covered in the chronic spontaneous urticaria market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Chronic Spontaneous Urticaria market, request a sample here.

Who are the major players in the Chronic Spontaneous Urticaria market?

Major companies operating in the chronic spontaneous urticaria market are developing advanced next-generation Briquilimab (JSP191) to enhance treatment efficacy and reduce dosing frequency. Next-generation Briquilimab (JSP191) refers to a monoclonal antibody designed to target and deplete specific immune cells, particularly targeting CD47, such as chronic spontaneous urticaria. For instance, in November 2023, Jasper Therapeutics Inc., a US-based clinical-stage biotechnology company, announced that it has dosed its first patient in a Phase 1b/2a clinical study of Briquilimab for chronic spontaneous urticaria (CSU). This achievement is a critical step in assessing the safety and effectiveness of Briquilimab, a next-generation monoclonal antibody that targets CD47, in the treatment of this recurrent hive and itching problem. The study aims to assess how well Briquilimab can alleviate symptoms and improve quality of life for patients suffering from CSU.. For further insights on the Chronic Spontaneous Urticaria market, request a sample here.

What are the key trends in the Chronic Spontaneous Urticaria market?

Major trends in the Chronic Spontaneous Urticaria market include Development Of Next-Generation Briquilimab (JSP191) To Enhance Treatment Efficacy. For further insights on the Chronic Spontaneous Urticaria market, request a sample here.

What are the major opportunities in the Chronic Spontaneous Urticaria market? What are the strategies for the Chronic Spontaneous Urticaria market?

For detailed insights on the major opportunities and strategies in the Chronic Spontaneous Urticaria market, request a sample here.

How does the Chronic Spontaneous Urticaria market relate to the overall economy and other similar markets?

For detailed insights on Chronic Spontaneous Urticaria's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Chronic Spontaneous Urticaria industry?

For detailed insights on the mergers and acquisitions in the Chronic Spontaneous Urticaria industry, request a sample here.

What are the key dynamics influencing the Chronic Spontaneous Urticaria market growth? SWOT analysis of the Chronic Spontaneous Urticaria market.

For detailed insights on the key dynamics influencing the Chronic Spontaneous Urticaria market growth and SWOT analysis of the Chronic Spontaneous Urticaria industry, request a sample here.